Contribution: Industrial Research Assistance Program – Contributions to Firms
DGI Clinical Inc.
$205,475.00
Development of the GoalNav Platform, a Clinical Trial System for Patient-Centric Outcomes Measurement
FY 2019-20 · 2019-07-08
Summary
Development of the GoalNav Platform, a clinical trial system for patient-centric outcomes measurement. This data capture system will be robust, secure, and scalable, supporting multiple simultaneous studies, across a mix of therapeutic areas.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Halifax|Halifax, Nova Scotia, Canada
Recipient Type
For-profit organization
Business Number
863915765
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2019-07-08 | 2019-20 | $149,000.00 |
| 1 | 2019-07-08 | 2019-20 | $205,475.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 78 days. The total amended value is 56,475 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 78 jours. La valeur totale des modifications est de 56 475 dollars.
Agreement End Date
2020-03-18
Agreement Number
931269
Agreement Start Date
2019-07-08
Agreement Title
Development of the GoalNav Platform, a Clinical Trial System for Patient-Centric Outcomes Measurement
Agreement Title (French)
Développement de la plate-forme GoalNav, un système d'essais cliniques pour la mesure des résultats centrés sur le patient
Agreement Type
Contribution
Agreement Value
$205,475.00
Amendment Date
2019-12-13
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Development of the GoalNav Platform, a clinical trial system for patient-centric outcomes measurement. This data capture system will be robust, secure, and scalable, supporting multiple simultaneous studies, across a mix of therapeutic areas.
Description (French)
Développement de la plate-forme GoalNav, un système d'essais cliniques pour la mesure des résultats centrés sur le patient. Ce système de saisie des données sera robuste, sécuritaire et évolutif, soutenant de multiples études simultanées, dans une combinaison de domaines thérapeutiques.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Halifax
Federal Riding (French)
Halifax
Federal Riding Number
12005
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
863915765
Recipient City
Halifax|Halifax
Recipient Country
CA
Recipient Legal Name
DGI Clinical Inc.
Recipient Postal Code
B3J 2E3
Recipient Province or Territory
NS
Recipient Type
F
Reference Number
172-2019-2020-Q2-931269
